GGHC
PACB icon

Gilder Gagnon Howe & Co’s Pacific Biosciences PACB Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-19,896
Closed -$508K – 416
2021
Q3 		$508K Sell
19,896
-341
-2% -$10.1K ﹤0.01% 345
2021
Q2 		$708K Sell
20,237
-69
-0.3% -$2.01K ﹤0.01% 344
2021
Q1 		$676K Sell
20,306
-24,125
-54% -$844K ﹤0.01% 311
2020
Q4 		$1.15M Buy
+44,431
New +$755K 0.01% 263
2018
Q1 		– Sell
-8,659
Closed -$23K – 302
2017
Q4 		$23K Sell
8,659
-14,372
-62% -$50.3K ﹤0.01% 291
2017
Q3 		$121K Sell
23,031
-1,116,552
-98% -$4.8M ﹤0.01% 257
2017
Q2 		$4.06M Sell
1,139,583
-2,479,394
-69% -$10M 0.06% 158
2017
Q1 		$18.7M Buy
3,618,977
+2,429,528
+204% +$11.9M 0.32% 77
2016
Q4 		$4.52M Sell
1,189,449
-2,046,497
-63% -$14.9M 0.09% 124
2016
Q3 		$29M Buy
3,235,946
+64,408
+2% +$538K 0.5% 60
2016
Q2 		$22.3M Sell
3,171,538
-46,320
-1% -$423K 0.44% 59
2016
Q1 		$27.4M Sell
3,217,858
-65,108
-2% -$640K 0.54% 49
2015
Q4 		$43.1M Buy
+3,282,966
New +$29.5M 0.69% 35

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Gilder Gagnon Howe & Co's PACB Position: Q4 2021 in Review

Gilder Gagnon Howe & Co sold out of Pacific Biosciences (PACB) in Q4 2021, closing a stake of 19,896 shares — an estimated $508K sold.

Gilder Gagnon Howe & Co first reported a position in PACB in Q4 2015 and held it in 13 quarters. The position peaked at $43.1M in Q4 2015. 256 funds tracked by Wall St. Rank hold PACB as of Q4 2021.

  • Gilder Gagnon Howe & Co reported no remaining Pacific Biosciences position as of Q4 2021 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 19,896 Pacific Biosciences shares in Q4 2021, an estimated $508K.
  • Gilder Gagnon Howe & Co first reported a position in Pacific Biosciences in Q4 2015 and held it in 13 quarters.
  • Gilder Gagnon Howe & Co's Pacific Biosciences position peaked at $43.1M in Q4 2015.
  • 256 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2021.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2021, filed 14 Feb 2022.